Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of BAG3 inhibitor in preparation of products for treating scars

A technology for scars and uses, applied in the direction of medical preparations containing active ingredients, pharmaceutical formulas, drug combinations, etc., can solve problems such as permanent radiation damage, limited clinical efficacy, toxicity, etc., achieve clear therapeutic targets and avoid the scope of treatment Small, low-cost synthetic effects

Active Publication Date: 2022-05-27
SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The limitations of the existing methods of prevention and treatment of pathological scars mainly include: 1. Surgical treatment: the treatment process is painful, the recurrence rate is high, and it is not suitable for patients with large area scars; 2. Pressure therapy: the effect is better for patients with large area burns , but the patient needs to wear an elastic compression device for a long time, causing serious inconvenience to life; 3. Radiotherapy: the therapeutic effect is limited, and often causes permanent radiation damage to the patient's whole body and local area; 4. Cryotherapy: only suitable for small scars, And treatment can cause skin pigmentation, skin atrophy and other complications; 5. Glucocorticoid treatment: can produce complications such as skin atrophy, telangiectasia, osteoporosis, female menstrual disorders, ulceration or calcification at the injection site; 6. Laser Therapy: low effective rate, easy to induce new scars; 7. Antineoplastic drug therapy (5-FU, etc.): it is also highly toxic to normal cells, and the clinical value is not yet clear; 8. Tacrolimus, statins Similar drugs, tamoxifen and other drugs: the clinical efficacy is limited, and the therapeutic target is not yet clear

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of BAG3 inhibitor in preparation of products for treating scars
  • Application of BAG3 inhibitor in preparation of products for treating scars
  • Application of BAG3 inhibitor in preparation of products for treating scars

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0021] The inventors of the present application have found that the expression of BAG3 gene in hypertrophic scar is significantly higher than that in normal skin. Based on this, the present invention provides the use of the BAG3 gene as a target in the preparation of a medicament for scar treatment or diagnosis.

[0022] In the present invention, the scar is selected from any of superficial scars, contracture scars, webbed scars, depressed scars, atrophic scars, bridging scars and hypertrophic scars, hypertrophic scars or keloid scars or variety.

[0023] Preferably, the scar is a hypertrophic scar.

[0024] Hypertrophic scar is a skin fibrotic disease, which is a fibro-metabolic disease of the skin dermis characterized by the uncontrolled proliferation of fibroblasts and the excessive production and deposition of a large amount of extracellular matrix such as collagen.

[0025] The use of the human BAG3 gene as a target in the preparation of a drug for scar treatment specif...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention relates to the field of medicines, in particular to application of a BAG3 inhibitor in preparation of a product for treating scars. The BAG3 inhibitor disclosed by the invention is clear in treatment target, and avoids the defects of unclear treatment mechanism, low efficiency, easiness in causing side effects and the like; a series of side effects possibly caused by hormone therapy are also avoided; normal cells of a human body cannot be damaged; new scar formation cannot be induced; large-area pathological scars can be treated; compared with the existing medicine, the medicine provided by the invention has a remarkable advantage in cost and is relatively low in synthesis cost.

Description

technical field [0001] The invention relates to the field of medicine, in particular to the use of a BAG3 inhibitor in the preparation of a product for treating scars. Background technique [0002] Hypertrophic scar is a common complication after wound / burn healing, which not only affects the patient's appearance, but also causes different degrees of functional impairment, such as tendon contracture, joint dislocation, and motor dysfunction, which seriously reduces the quality of life of patients. Later treatment brings a heavy economic and psychological burden. According to statistics, the incidence of hypertrophic scar after burn is 91.4%. If the healing time of burn wound is more than 2 weeks, the incidence of hypertrophic scar is as high as 74.67%. The research on the prevention and treatment of scar is an ancient and novel topic. Studies have found that scarring is an excessive healing response of the human body to trauma, leading to a fibrometabolic disease in the de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K45/00A61K31/713A61P17/02
CPCA61K45/00A61K31/713A61P17/02Y02A50/30
Inventor 张艺凡温东晟高雅侯家康李青峰
Owner SHANGHAI NINTH PEOPLES HOSPITAL SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products